Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3546265 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRGLAKMT2AMEN1 | |
| SCHEMBL2079053 | 0.84 | ALDH1A1 (0.49) | ALDH1A1TSHRGLAKMT2AMEN1 | |
| Propane SCHEMBL3346178 | 0.78 | KMT2A (0.47) | ALDH1A1TSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL2893483 | 0.76 | KMT2A (0.51) | ALDH1A1TSHRGLAKMT2AMEN1 | |
| SCHEMBL237873 | 0.76 | KMT2A (0.51) | ALDH1A1TSHRGLAKMT2AMEN1 | |
| SCHEMBL12892655 | 0.76 | SMN1; SMN2 (0.49) | ALDH1A1GLAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL16093068 | 0.75 | KMT2A (0.50) | ALDH1A1TSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL28870216 | 0.74 | KDM4E (0.48) | ALDH1A1TSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL28870213 | 0.74 | KDM4E (0.48) | ALDH1A1TSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL13305899 | 0.73 | NPSR1 (0.45) | ALDH1A1KMT2AMEN1SMN1; SMN2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1400508-B1 | Dithiocarbamic acid ester | LANXESS DEUTSCHLAND GMBH (DE) | 2014-12-24 | — | — | EP | disclosed |
| US-7977431-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2011-07-12 | — | — | US | disclosed |
| US-7977431-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2011-07-12 | — | — | US | disclosed |
| US-7977431-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2011-07-12 | — | — | US | disclosed |
| US-20110015360-A1 | DITHIOCARBAMIC ESTERS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| US-20110015360-A1 | DITHIOCARBAMIC ESTERS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| US-20110015360-A1 | DITHIOCARBAMIC ESTERS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| US-7825193-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2010-11-02 | — | — | US | disclosed |
| US-7825193-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2010-11-02 | — | — | US | disclosed |
| US-20070078229-A1 | suitable for regulating the molecular weight during the polymerization of chloroprene and/or 2,3-dichlorobutadiene; compound purity; no sacrifice of polymerization rate; efficient; industrial scale | ARLANXEO DEUTSCHLAND GMBH (DE) | 2007-04-05 | — | — | US | disclosed |
| US-20070078229-A1 | suitable for regulating the molecular weight during the polymerization of chloroprene and/or 2,3-dichlorobutadiene; compound purity; no sacrifice of polymerization rate; efficient; industrial scale | ARLANXEO DEUTSCHLAND GMBH (DE) | 2007-04-05 | — | — | US | disclosed |
| US-7169937-B2 | Dithiocarbamic esters | BAYER AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-7169937-B2 | Dithiocarbamic esters | BAYER AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078229-A1 | suitable for regulating the molecular weight during the polymerization of chloroprene and/or 2,3-dichlorobutadiene; compound purity; no sacrifice of polymerization rate; efficient; industrial scale | DDT, DHPS, CBR3 | ALDH1A1 1419/4885TSHR 2619/4885GLA 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.